Long-term efficacy and safety of the Port Delivery System with ranibizumab in patients with neovascular age-related macular degeneration: Results from the Portal 5-year subgroup analysis

被引：0
|
作者：
Howard, James [1 ]
Cordeiro, Melina Cavichini [2 ]
Singh, Natasha [2 ]
Gune, Shamika [2 ]
机构：
[1] Retina Associates Utah, Salt Lake City, UT USA
[2] Genentech Inc, South San Francisco, CA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Interim analysis of the Portal extension trial evaluating the long-term safety and efficacy of the Port Delivery System with ranibizumab (PDS) in neovascular age-related macular degeneration (nAMD)
    Haug, Sara
    Callaway, Natalia
    DeGraaf, Stephanie
    LePogam, Sophie
    Rabena, Mel
    Smith, Rob
    Barteselli, Giulio
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [2] Long-term Safety of Ranibizumab in Neovascular Age-related Macular Degeneration
    Matonti, Frederic
    Courjaret, Jean Christophe
    Hoffart, Louis
    Amouyal, Franck
    Denis, Daniele
    OPHTHALMOLOGY, 2013, 120 (09) : E68 - E69
  • [3] Ranibizumab port delivery system in neovascular age-related macular degeneration
    Chandrasekaran, Priya R.
    Madanagopalan, V. G.
    THERAPEUTIC ADVANCES IN OPHTHALMOLOGY, 2022, 14
  • [4] Long-term Safety of Ranibizumab in Neovascular Age-related Macular Degeneration Reply
    Silva, Rufino
    Axer-Siegel, Ruth
    Eldem, Bora
    Guymer, Robyn
    Kirchhof, Bernd
    Papp, Andras
    Seres, Andras
    Gekkieva, Margarita
    Nieweg, Annette
    Pilz, Stefan
    OPHTHALMOLOGY, 2013, 120 (09) : E69 - E69
  • [5] LONG-TERM EFFICACY OF RANIBIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Chang, Andrew A.
    Chew, Jamie
    Syed, Adil
    Joachim, Nichole
    Li, Haitao
    Broadhead, Geoffrey K.
    Zhu, Meidong
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 41 : 98 - 98
  • [6] Development of the Port Delivery System with ranibizumab for neovascular age-related macular degeneration
    Adamis, Anthony P.
    de Juan, Eugene, Jr.
    CURRENT OPINION IN OPHTHALMOLOGY, 2022, 33 (03) : 131 - 136
  • [7] Evaluation of Port Delivery System with ranibizumab for the treatment of neovascular age-related macular degeneration
    Patel, Annika J.
    Pieramici, Dante J.
    Bagheri, Nika
    THERAPEUTIC DELIVERY, 2021, 12 (03) : 191 - 200
  • [8] Cost-Utility Analysis of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
    Brown, Gary C.
    Brown, Melissa M.
    Monigle, Meg C.
    OPHTHALMOLOGY RETINA, 2024, 8 (05): : 431 - 446
  • [9] Ranibizumab in neovascular age-related macular degeneration: a 5-year follow-up
    Cvetkova, Nadezhda P.
    Hoelldobler, Kristina
    Prahs, Philipp
    Radeck, Viola
    Helbig, Horst
    Maerker, David
    CLINICAL OPHTHALMOLOGY, 2016, 10 : 1047 - 1051
  • [10] Infographic: The port delivery system with ranibizumab for neovascular age-related macular degeneration: LADDER trial
    Barai, Ishani
    Sivaprasad, Sobha
    Henein, Christin
    EYE, 2024, : 126 - 128
12345